Left Main Coronary Artery Interventions-Reference-Cited by-同舟云学术

Left Main Coronary Artery Interventions

Published:2019-11-18 Issue:3 Volume:14 Page:124-130
ISSN:1756-1485
Container-title:Interventional Cardiology Review
language:en
Short-container-title:Interv Cardiol

Author:

Alasnag Mirvat¹,Yaqoub Lina²,Saati Ammar³,Al-Shaibi Khaled¹

Affiliation:

1. King Fahd Armed Forces Hospital, Jeddah, Saudi Arabia

2. Louisiana State University, LA, US

3. Brown University, RI, US

Abstract

The management of left main coronary artery (LMCA) disease has evolved over the past two decades. Historically, coronary artery bypass grafting (CABG) surgery has been the gold standard for the treatment of LMCA disease. However, with the advancements in percutaneous coronary interventions (PCIs) and stent technology, PCI in select patients has achieved comparable outcomes to CABG. As such, this has led to changes in the American College of Cardiology and European Society of Cardiology guidelines, which recommend that PCI might be an alternative to CABG in select patients. In this review article, we describe the historical perspective and early experience with coronary interventions of LMCA disease, landmark clinical trials and their effect on guidelines, and the role of intravascular imaging in the management of LMCA lesions.

Publisher

Radcliffe Group Ltd

Subject

Cardiology and Cardiovascular Medicine

Reference25 articles.

1. 1. Ragosta M. Left main coronary artery disease: importance, diagnosis, assessment, and management. Curr Probl Cardiol 2015;40:93–126. https://doi.org/10.1016/j.cpcardiol.2014.11.003; PMID: 25765453.

2. 2. Gruntzig AR, Senning A, Siegenthaler WE. Nonoperative dilatation of coronary-artery stenosis: percutaneous transluminal coronary angioplasty. N Engl J Med 1979;301:61–8. https://doi.org/10.1056/NEJM197907123010201; PMID: 449946.

3. 3. Boudriot E, Thiele H, Walther T, et al. Randomized comparison of percutaneous coronary intervention with sirolimus-eluting stents versus coronary artery bypass grafting in unprotected left main stem stenosis. J Am Coll Cardiol 2011;57:538–45. https://doi.org/10.1016/j.jacc.2010.09.038; PMID: 21272743.

4. 4. Morice MC, Serruys PW, Kappetein AP, et al. Five-year outcomes in patients with left main disease treated with either percutaneous coronary intervention or coronary artery bypass grafting in the synergy between percutaneous coronary intervention with taxus and cardiac surgery trial. Circulation 2014;129:2388–94. https://doi.org/10.1161/CIRCULATIONAHA.113.006689; PMID: 24700706.

5. 5. Ahn JM, Roh JH, Kim YH, et al. randomized trial of stents versus bypass surgery for left main coronary artery disease: 5-year outcomes of the PRECOMBAT Study. J Am Coll Cardiol 2015;65:2198–206. https://doi.org/10.1016/j.jacc.2015.03.033; PMID: 25787197.

Cited by 8 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Single-stent strategy for left coronary artery bifurcation lesions in patients with chronic ischemic heart disease: protocol of a randomized trial;Russian Journal of Cardiology;2023-05-21

2. The Degree of Stent Apposition Measured by Stent Enhancement at the Level of the Side Branch as a Novel Predictor of Procedural Success in Left Main PCI;Journal of Personalized Medicine;2023-05-03

3. Comparative efficacy of eight therapeutic methods in the treatment of left main coronary artery disease: a Bayesian network meta-analysis protocol;BMJ Open;2022-09

4. New Forms of Electrospun Nanofibers Applied in Cardiovascular Field;Frontiers in Cardiovascular Medicine;2022-01-21

5. ECPella: High-risk percutaneous coronary intervention in cardiogenic shock “case report”;Saudi Critical Care Journal;2022